Israeli Ministry of Health Actually Did Survey of Adverse Events

Written by Josh Guetzkow on February 21, 2022. Posted in Current News

The Israeli Ministry of Health (MoH) conducted an actual survey of about two thousand people 3-4 weeks after they received the third (booster) shot of the Pfizer/BioNTech COVID-19 vaccine, asking them about the adverse events they experienced following vaccination.

The results are absolutely devastating to the COVID-19 vaccine program and the push for vaccine mandates. They come to me from my brother-in-arms. ‘Galileo is Back’ (and boy is he pissed!).

The survey report was released last week (Feb. 9) and from what I could find it is not available on the MoH website but only via a website for medical staff only, so it is not publicly available. (Correction: it was released on the MoH Telegram channel.)

The report was greeted by the media mainly with near dead silence, aside from a couple of articles downplaying the adverse events as mild and transient.

This is after more than a year that every talking head on TV and every newspaper large and small assured the Israeli public that they were monitoring the safety of the vaccines and that they were obviously extremely safe because there were very few reports and most of them were extremely minor and you were a crazy conspiracy theorist to doubt it.

Of course the MoH, along with the CDC, completely ignores the unambiguous and unprecedented safety signals emanating from the US Vaccine Adverse Events Reporting System (VAERS). Never mind that the passive, voluntary adverse events reporting system that the MoH put into place, which basically nobody knew about, was a complete farce.

They took a page from the Pharma playbook by deliberately failing to gather data appropriately so they could turn absence of evidence into evidence of absence.

The MoH didn’t have to look further than their own Facebook page to find plenty of evidence. On Sept. 30 they put up a Facebook post deriding all the “fake news” on social networks about side effects and touting the safety of the vaccines: only 19 serious adverse events reported out of 3 million booster doses, which might not even be related to the vaccine.

The post was quickly flooded with thousands of comments from people describing in detail the severe adverse events they or their loved ones had experienced after the booster and previous doses (see here for automated translation of many of them).

Somebody at the MoH apparently panicked, because they quickly started deleting hundreds if not thousands of comments. They were caught ‘in the act’ by people reading the comments who took videos of them being deleted, one by one. There are currently 27,000 comments on that post. It is unknown how many were deleted.

And apparently it had never occurred to the MoH to investigate why so many people never returned for the second dose, despite losing eligibility for the green pass or the right to work in countless workplaces requiring vaccination. One careful calculation I’ve seen estimated that by June 2021, there were about 180,000 people who had never returned for the second dose—a number that excludes people who recovered from a SARS-Cov-2 infection.

That’s over three percent of people who were vaccinated with one dose and eligible for the second at that time.

At the FDA advisory committee hearing on Sept. 17 to decide whether to approve the booster shot, Israel’s data on the 3rd dose played a starring role — including their safety data. It was extremely safe, they assured the FDA, as they had received so few reports, even less than the first two doses!

And even most of the ones they did receive were not caused by the vaccine, including this woman in her 60’s who had a stroke immediately after receiving the booster dose.

Why wasn’t it causally related? Because they said so.

While the FDA panel applauded Israel for being an exemplary laboratory (I wish I was joking), they nevertheless decided that the Israeli data was insufficient to approve the booster for people under 65. The MoH was undeterred.

Thanks in part to the new policy requiring a third dose for “green pass” eligibility that prompted many reluctant young Israelis to go in for dose #3 along with the army forcing it on draftees, they were able to return to the FDA the following month (Oct 14) with more data they had gathered on the effectiveness and safety of the booster dose in younger populations, again with the same conclusion: extremely safe.

Like so, so safe. Never mind all those pesky Facebook posts and people who never returned for dose 2.

Meanwhile, the survey they were conducting on adverse events after the booster, which paints a completely different picture about its safety profile, was wrapping up and would be finished less than two weeks later on Oct. 25th. It’s worth noting that the MoH had ample time to analyze the survey data before recommending the 4th booster dose on January 25.

So what do the survey results tell us about the safety of the booster dose? And what can they tell us about the extent to which the existing Israeli vaccine safety monitoring system was undercounting adverse events?

And can we use them to estimate the underreporting factor for some events in VAERS? (Short answers: horrible safety, massively undercounted, and yes we can!)

Here are some of the most important takeaways from the survey. Further down I’ll present all the results and conclude with some discussion of unreported events:

• 0.5 percent of people reported hospitalization as a result of the adverse event they experienced. Not just the emergency room, but actually being hospitalized. Think this is impossibly high? Read this footnote.1 If the numbers are wrong, the MoH needs to say so and explain how they messed up.
  • Israel has administered about 4.5 million booster doses so far, which equates to over 22,000 hospitalizations.
  • Over 92 million booster doses have been distributed in the U.S., which equates to 460,000 hospitalizations.
• 29 percent reported that they had difficulty performing daily activities as a result of the adverse event. That is 44 percent of the 66.4 percent of the sample that reported at least one adverse event. Like in VAERS, women were more likely to report than men (75 percent vs. 58 percent) and also more likely to report difficulty in daily functioning (51 percent vs 35 percent).
• 4.5 percent of respondents reported neurological problems (again, more women than men), including:
  • Bell’s Palsy (0.5 percent)
  • Blurred or disturbed vision (0.5 percent)
  • Seizures/Convulsions (0.15 percent)
  • Loss of consciousness (0.2 percent)
  • 16 percent of these neurological problems occurred within an hour of vaccination, an additional 27 percent within 24 hours, and 47 percent were ongoing by the time of the survey 3-4 weeks after vaccination.
  • In the US, this translates to 460,000 cases of Bell’s Palsy and blurred or disturbed vision, 135,000 seizures and 180,000 people losing consciousness.
  • Have you ever heard of a vaccine that is associated with seizures in 0.15 percent of adults who take it — let alone one that is mandated by many colleges and workplaces?
• About 25 percent of people with pre-existing auto-immune disorders, depression or anxiety reported a worsening of their symptoms following the booster. Five to ten percent of people with diabetes, hypertension, and lung & heart disease also reported a worsening of their condition.
• Nearly 10 percent of women under age of 54 had disruptions to their menstrual cycle after the booster (apparently they did not ask women above this age). About half of those women reported that the problems persisted at the time of a follow-up interview, which was anywhere from 10-16 weeks after vaccination.
  • Of these, 31 percent sought medical treatment as a result and nine percent were on medication for it.
  • Notably, 39 percent of these women reported similar disruptions following prior doses, of whom 1/3 (which is a little over 6 percent of all women under the age of 54) were still experiencing symptoms at the time of the 3rd dose. Given that the vast majority of vaccinated Israelis were “fully vaccinated” by the end of March and the booster campaign for that age group didn’t get into full swing until late August, this means that these women were likely experiencing these symptoms for somewhere between 4-months.
• How badly did the Israeli vaccine adverse event reporting system undercount adverse events? We can calculate an approximation by comparing the MoH’s Sept. 25 report on adverse events from this system to the survey results to calculate an “underreporting factor” (URF). If the URF is 100, this means you have to multiply the number of reported events by 100 to approximate the true number of adverse events.2 It’s especially important to know the URF when public health officials disingenuously play down the risks of a medical product by saying that there have been very few reports of adverse events, while knowing full well that the true number must be much larger. The only question is — how much larger?
  • The URF varies from a low of 1,700 for loss of consciousness to 48,800 for difficulty breathing. Some other highlights: a URF of 6,500 for seizures, nearly 6,000 for Bell’s Palsy, and over 4,000 for blurry or disturbed vision.
  • Actually the URF was even higher for some milder, general AE’s and for local site reactions: 54,000 for chest pains, 230,000 for limited arm movement, and 540,000 for injection site pain. That these types of AE’s are so underreported is hardly surprising: the public was told to expect these kinds of reactions, and for the most part they are relatively minor (though note in the last table below how long some of them persist for).
  • Note that these URF’s cannot be applied to VAERS, for two reasons:
    • The underreporting in Israel is probably much worse than in the US for a variety of reasons.
    • Israel does not conform to the international classification standard for AE reporting. The US, UK and Europe use the MedDRA system. The Israeli MoH apparently decided to make up its own classification system and continues to use it, for reasons unknown. So comparison to other countries is difficult.

Still we can use the survey results to estimate VAERS underreporting for three specific adverse reactions: Seizures, Bell’s Palsy, and shingles (herpes zoster).

• VAERS URF for Seizures/Convulsions is 731:
  • As of Feb. 11, there were 243 reports of seizures and convulsions reported in VAERS that occurred within 30 days of receiving the booster dose in the US and territories (143 of these were after Pfizer).
  • As of Feb. 11, about 91 million booster doses had been administered in the US, of which about 50 million were from Pfizer.
  • The rate of per million doses of seizures/convulsions in the MoH survey was 1952 (see footnote 3 for method of calculation).
  • From that rate the expected number of seizures/convulsions after the booster in the US by Feb. 11 is 177,600.3
  • 177,600/91 = 731. If we want to make a strict apples-to-apples comparison, we need to look at reports after Pfizer only, in which case the URF is 683.
• VAERS URF for Bell’s Palsy is 3,034:
  • As of Feb. 11, there were 161 cases of Bell’s Palsy listed in VAERS (95 of these were after Pfizer).
  • The rate per million doses of Bell’s Palsy in the MoH survey was 5,368.
  • The expected number of cases of Bell’s Palsy after the booster is 488,500.
  • 488,500/161 = 3,034. For Pfizer it’s 2,825.
• VAERS URF for shingles (herpes zoster) is 401.
  • As of Feb. 11, there were 332 cases of shingles reported in VAERS (196 after Pfizer).
  • The rate per million doses of herpes zoster in the MoH survey was 1,464.
  • The expected number of Herpes Zoster cases after the booster in the US is 133,200.
  • 133,200/332 is 401. For Pfizer only it’s 373.
• Here is a table summarizing the URF calculations for these three AE’s:

Do you know of any other mandated medical treatment or vaccine that causes so many problems in such a high proportion of the population? For that matter, how many mandated medical treatments have you ever even heard of?

The results of this survey should have put an immediate end to the plans of governments around the world to continue to offer booster doses to their citizens, let alone condition basic liberties on getting one. And yet, here we are. The only question now is how much lower this report can limbo under the radar.

Below are tables showing the number and percent of reports from the survey and comparing those results, where possible, to the MoH report based on the passive surveillance system.

I’ve also calculated the estimated total number of events that would be expected to occur in the US and Israel based on the survey reporting rate per million and the total number of booster doses administered in each country, based on approximately 92 million doses administered in the US and 4.5 million in Israel.

The full tables, including a gender breakdown, are available here. To read more about how the URF was calculated, read this footnote.4 I’m not going to add much commentary on the tables as they sort of speak for themselves.

I’m also not going to show a table for local administration site reactions, as they are relatively less sever and less interesting (though note in the last table how long many of them last for).

Let’s start with some of the more serious AE’s, starting with Neurological:

Here is the table for allergic reactions. They say no cases of anaphylaxis were reported during the survey, but difficulty breathing and throat swelling are anaphylactic reactions, even if they do not reach the severity of full-blown anaphylaxis.

Here are reactions classified as “general:”

Here is a table showing what percentage of respondents had pre-existing chronic illnesses and, of those, what percentage experienced a worsening of symptoms after the booster dose:

Wait, weren’t the vaccines were supposed to protect people at greater risk of severe COVID outcomes, not make them worse?

Here are three AE’s that were not reported by the MoH in its report on its spontaneous AE monitoring system, so a URF cannot be calculated (Note: table is corrected from earlier draft):

A follow-up study of the women who reported menstrual changes was conducted 7-12 weeks after the first interview. About half of them were still experiencing problems at the time of the follow-up. Here is the breakdown of the kinds of changes they experienced (categories are not mutually exclusive).

Finally, here is a table reporting how soon after vaccination they experienced the adverse event for different categories and the duration of the symptoms. Note that a sizeable percentage of symptoms are listed as “ongoing,” meaning they were still experiencing symptoms from the adverse event at the time of the interview 3-4 weeks following receipt of the booster dose.

A sizeable percentage of events began on the same day as the vaccination. But as we saw at the top, even if you have a stroke the moment the shot goes into you, it may still be ruled a “coincidence” by the wise sages in the Ministry of Health. To them I say: don’t piss on my leg and tell me it’s raining.

They’re engaged in an exercise of ghoulish gaslighting, and I honestly wonder how they sleep at night. To give them the benefit of the doubt, instead of being motivated by malevolence their actions might be due to arrogance allied with ignorance: since they don’t know how the vaccines could possibly cause a particular problem, then obviously they couldn’t have.

Because they know everything. Apparently. And you dare not question them or you will be shunned from polite society.

I will save a deep-in-the-weeds methodological discussion for the final footnote,5 but it’s worth pointing out as I wrap this up that the survey is also notable for the events it doesn’t include.

They did report one case of myocarditis. According to Israeli figures, the highest rate of myocarditis following the second dose for every 6,600 boys aged 16-19 and significantly less for older people and females. So it is quite remarkable that even 1 case was observed in this survey of 2,049 people, few of whom were in the highest risk category for myocarditis.

This means either that it was a fluke or that the chances of myocarditis are significantly larger following the booster dose.

This is taken from a long document. Read the rest here: substack.com

Header image: Novocol Pharma

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.